Most of the lesions in this small cohort showed, compared to baseline, a decrease in PSMA PET tracer uptake and serum PSA concentrations and higher ADC values at end of ADT treatment (Table 2; Figs. 2 and 3), consistent with ADT treatment-induced reduction in tumour cellularity throughout the study period. This evidence concerns the gene KLK3 and neoplasm.